The Challenge: How to unveil competitors’ plans and gain a strategic edge
A player in the hemophilia space partnered with LucidQuest to gain valuable insights into key competitor activities and their plans in both the US and EU markets.
The Action: Primary research with KOLs and competitor sources
LucidQuest’s expert team conducted targeted primary research, engaging with Key Opinion Leaders (KOLs) and reliable sources from key competitors to obtain up-to-date intelligence on their discussions with regulators and payors regarding clinical and regulatory timelines and clinical development programs for key competitors’ hemophilia assets.
The Result: Improved decision-making due to competitive intelligence
The client used the intelligence provided as part of the knowledge book for a strategic workshop, which LucidQuest also facilitated, leading to a strengthened strategic decision-making process around its hemophilia business.
#Hemophilia #CompetitiveIntelligence #PharmaStrategy #ClinicalDevelopment #casestudy #ourwork